Koers Hua Medicine (Shanghai) Ltd. OTC Markets
Aandelen
HUMDF
KYG4644K1022
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,2028 USD | -54,93% | -.--% | -.--% |
Omzet 2023 | 76,61 mln. 10,58 mln. 9,85 mln. | Omzet 2024 * | 594 mln. 82,07 mln. 76,44 mln. | Marktkapitalisatie | 1,46 mld. 202 mln. 188 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -211 mln. -29,14 mln. -27,14 mln. | Nettowinst (verlies) 2024 * | -233 mln. -32,18 mln. -29,97 mln. | EV/omzet 2023 | 22,9 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 2,46 x |
K/w-verhouding 2023 |
-8,14
x | K/w-verhouding 2024 * |
-6,28
x | Werknemers | 177 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 86,36% |
Recentste transcriptie over Hua Medicine (Shanghai) Ltd.
1 dag | -54,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Chen
FOU | Founder | 61 | 10-11-09 |
Li Changhong
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Di Hong
COO | Chief Operating Officer | 45 | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Nelsen
CHM | Chairman | 60 | 23-04-10 |
William Keller
BRD | Director/Board Member | 75 | - |
Yiu Wa Tsui
BRD | Director/Board Member | 74 | 01-09-18 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 103 mld. | |
+6,75% | 101 mld. | |
+5,82% | 23,07 mld. | |
-12,60% | 22,23 mld. | |
-9,70% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,17% | 16,94 mld. | |
+6,12% | 14,07 mld. | |
+35,47% | 12,35 mld. |
- Beurs
- Aandelen
- Koers 2552
- Koers HUMDF